Monistat vs Diflucan for Yeast Infection During Pregnancy

How do the options compare?

The comparison below weighs mainstream OB guideline standing, the depth of the pregnancy evidence base, dosing clarity, expected onset, and interactions worth flagging to your provider.

• MotherToBaby says topical or vaginal miconazole is not well absorbed, so less medicine reaches the developing fetus; most low-dose studies have not found a higher chance of birth defects. 1
• The current CDC sexually transmitted infection guideline recommends only topical azole therapies for seven days for vulvovaginal candidiasis in pregnancy and says a single 150 mg fluconazole dose should not be used. 2
• MotherToBaby reports mixed miscarriage findings for oral fluconazole, notes study limitations including prescription-record exposure, and says the FDA found no definite evidence of higher miscarriage risk with a single 150 mg dose. 3
• A review of oral fluconazole concludes that topical imidazoles are preferred in pregnancy because systemic absorption is minimal and available oral-fluconazole safety evidence remains uncertain. 4
• The current DailyMed fluconazole label reports a pattern of congenital anomalies after 400 to 800 mg daily during most or all of the first trimester and describes potential risk with first-trimester exposure. 5

Which option makes sense?

The options above differ in their evidence, limitations, and suitability. Inclusion in this comparison is not a recommendation. Please consult your healthcare provider before making a decision based on these findings.

Disclosure: Pregnancy Smart makes pregnancy supplements, though not in this category. This comparison is a plain description of the pregnancy evidence, not a sales page.